Almirall, S.A. - Company & Market Research Reports

Almirall is a pharmaceutical company that develops, manufactures, and sells medicines and medical devices worldwide. Its products are available in over 70 countries on five continents, through 13 affiliates. Its product offering includes dermatological diseases comprising actinic keratosis, psoriasis, eczema, and skin infections; respiratory; gastrointestinal and metabolism; central nervous system; and other therapeutic specialties. Founded in 1943, it is headquartered in Barcelona, Spain.

From
From
From
From
From
From
Psoriasis - Pipeline Review, H2 2018 - Product Thumbnail Image

Psoriasis - Pipeline Review, H2 2018

  • Drug Pipelines
  • 726 Pages
From
Psoriasis - Pipeline Review, H1 2018 - Product Thumbnail Image

Psoriasis - Pipeline Review, H1 2018

  • Drug Pipelines
  • 709 Pages
From
From
Severe Psoriasis - Pipeline Insight, 2018 - Product Thumbnail Image

Severe Psoriasis - Pipeline Insight, 2018

  • Drug Pipelines
  • 50 Pages
From
Moderate Psoriasis - Pipeline Insight, 2018 - Product Thumbnail Image

Moderate Psoriasis - Pipeline Insight, 2018

  • Drug Pipelines
  • 50 Pages
From
Plaque Psoriasis - Pipeline Insight, 2018 - Product Thumbnail Image

Plaque Psoriasis - Pipeline Insight, 2018

  • Drug Pipelines
  • 50 Pages
From
From
Rosacea - Pipeline Review, H1 2018 - Product Thumbnail Image

Rosacea - Pipeline Review, H1 2018

  • Drug Pipelines
  • 61 Pages
From
From
From
From
Loading Indicator
adroll